Skip to main content
Rahul Banerjee, MD, Oncology, Seattle, WA

RahulBanerjeeMDFACP

Oncology • Seattle, WA

Hematologic Oncology

Assistant Professor, Division of Medical Oncology (focus: multiple myeloma)

Join to view full profile

Dr. Banerjee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Banerjee's full profile

Already have an account?

  • Office

    825 Eastlake Ave E
    Seattle, WA 98109
    Phone+1 206-520-5000

Summary

  • Dr. Rahul Banerjee, MD, FACP, (Twitter/X: @RahulBanerjeeMD) is an Assistant Professor at the Fred Hutchinson Cancer Center and at the University of Washington in Seattle, WA. His clinical interests are in multiple myeloma and CAR-T therapy. He is a member of the International Myeloma Working Group and has published over 80 peer-reviewed publications with an emphasis on improving the experiences of patients as they undergo treatment for multiple myeloma.

Education & Training

  • University of California San Francisco
    University of California San FranciscoAdvanced Fellowship, BMT/CAR-T Therapy, 2021 - 2022
  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2018 - 2021
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemChief Residency, Internal Medicine, 2017 - 2018
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2014 - 2017
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemInternship, Internal Medicine, 2014 - 2015
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 2014, MD, AOA Inductee

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2022 - 2027
  • AK State Medical License
    AK State Medical License 2025 - 2026
  • CA State Medical License
    CA State Medical License 2018 - 2026
  • ID State Medical License
    ID State Medical License 2024 - 2026
  • MT State Medical License
    MT State Medical License 2024 - 2026
  • PA State Medical License
    PA State Medical License 2014 - 2018
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Winner, Department of Medicine ‘Shelter-in-Poetry’ Competition University of California San Francisco, 2020
  • Penn Pearls Award Recipient Perelman School of Medicine, University of Pennsylvania, 2017
  • Samaha Award for resident scholarship Penn Medicine, 2017
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Illiteracy  
    Banerjee R, The Pharos of Alpha Omega Alpha Honor Medical Society, 2/21/2017

Books/Book Chapters

  • The 5-Minute Clinical Consult 
    Chapter: Autoimmune Hemolytic Anemia 
    Hue HJ, Lau ES, Banerjee REditors: Domino FJ.Lippincott Williams and Wilkins
  • The 5-Minute Clinical Consult 
    Chapter: Porphyria 
    Hue HJ, Lau ES, Banerjee REditors: Domino FJ.Lippincott Williams and Wilkins

Abstracts/Posters

  • Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Mu...
    Rahul Banerjee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • KMN 2025: How Lower Dexamethasone Dose Doesn’t Impair Survival in a Number of Myeloma
    KMN 2025: How Lower Dexamethasone Dose Doesn’t Impair Survival in a Number of MyelomaJanuary 25th, 2025
  • Lower Dexamethasone Dose Does Not Impair Survival in Multiple Myeloma
    Lower Dexamethasone Dose Does Not Impair Survival in Multiple MyelomaJanuary 24th, 2025
  • Lower Dexamethasone Dose Does Not Impair Survival in Multiple Myeloma
    Lower Dexamethasone Dose Does Not Impair Survival in Multiple MyelomaJanuary 24th, 2025
  • Join now to see all

Grant Support

  • Young Investigator AwardASCO Conquer Cancer Foundation2020–2022

Professional Memberships

Other Languages

  • Hindi, Bengali

Dr. Rahul Banerjee, Dr. Rahul Banerjee, MD, Dr. R Banerjee